The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases
Prashant Deshmukh(Rajendra Hospital), Balasundaram Padmanabhan(National Institute of Mental Health and Neurosciences)
Cited by 389
Related Papers
No related papers found
Powered by citation graph analysis